1. Home
  2. KOD

as 09-15-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Founded: 2009 Country:
United States
United States
Employees: N/A City: PALO ALTO
Market Cap: 198.4M IPO Year: 2018
Target Price: $11.75 AVG Volume (30 days): 556.4K
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.79 EPS Growth: N/A
52 Week Low/High: $1.92 - $11.60 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

KOD Daily Stock ML Predictions

Share on Social Networks: